<p>Mice were immunized with three doses of PBS/2M urea (PBS) or E6E7 in intervals of 14 days. Mice were challenged with TC-1 tumor cells two weeks after the last dose. (A) Groups of five C57BL/6 mice were immunized as described. (B) TLR4 KO mice (C57BL10/ScCr) were vaccinated with PBS/2M urea (5 mice, PBS) or E6E7 (6 mice). (C) Groups of eight CD4 KO mice were vaccinated with PBS/2M urea (PBS) or E6E7. (D) Groups of five CD8 KO mice were vaccinated with PBS/2M urea (PBS) or E6E7. In parallel, C57BL/6 wild-type mice (5 mice) were used as a control of tumor growth competence. Asterisk indicates statistically significant percentage of tumor-free animals when compared to control group (** p < 0.005).</p
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>Six mice/group were immunized three times with P<sub>5+435</sub> long peptide alone, long peptide...
<p>(A) C57BL/6 mice were immunized with three doses of PBS/2M urea (PBS) or E6E7 protein vaccine and...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Numbers of (<b>A</b>) E6-specific CD8<sup>+</sup> T precursors and (<b>B</b>) E7-specific CD8<sup...
<p>(<b>a</b>) Mice were immunized twice by subcutaneous injection of rE7m/rlipo-E7m (10 µg) or PBS a...
<p>Tumor inoculation and vaccination was performed as described above except that some groups of the...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p><i>In </i><i>vivo</i> tumor protection experiments of the mice vaccinated with (<b>A</b>) respect...
TS/A cells (a Balb/c-derived tumor cell line), when injected into syngenic mice, give rise to rapidl...
<p>(a) C57BL/6 mice (eight per group) were inoculated with 1×10<sup>5</sup> TC-1 tumour cells/mouse ...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Two weeks after the last boost, five vaccinated mice for each group were challenged by subcutaneo...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>Six mice/group were immunized three times with P<sub>5+435</sub> long peptide alone, long peptide...
<p>(A) C57BL/6 mice were immunized with three doses of PBS/2M urea (PBS) or E6E7 protein vaccine and...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p>Numbers of (<b>A</b>) E6-specific CD8<sup>+</sup> T precursors and (<b>B</b>) E7-specific CD8<sup...
<p>(<b>a</b>) Mice were immunized twice by subcutaneous injection of rE7m/rlipo-E7m (10 µg) or PBS a...
<p>Tumor inoculation and vaccination was performed as described above except that some groups of the...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p><i>In </i><i>vivo</i> tumor protection experiments of the mice vaccinated with (<b>A</b>) respect...
TS/A cells (a Balb/c-derived tumor cell line), when injected into syngenic mice, give rise to rapidl...
<p>(a) C57BL/6 mice (eight per group) were inoculated with 1×10<sup>5</sup> TC-1 tumour cells/mouse ...
<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77...
<p>Two weeks after the last boost, five vaccinated mice for each group were challenged by subcutaneo...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>Six mice/group were immunized three times with P<sub>5+435</sub> long peptide alone, long peptide...